Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.13), $0.46 better than the analyst estimate of ($0.59). Revenue for the quarter came in at $3.56 million, versus $0 reported last year.

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.